193 related articles for article (PubMed ID: 2436423)
1. A preliminary study of the effect of 11a-hydroxyprogesterone on the hair growth in men suffering from androgenetic alopecia.
van der Willigen AH; Peereboom-Wynia JD; van Joost T; Stolz E
Acta Derm Venereol; 1987; 67(1):82-5. PubMed ID: 2436423
[TBL] [Abstract][Full Text] [Related]
2. The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females.
Peereboom-Wynia JD; van der Willigen AH; van Joost T; Stolz E
Acta Derm Venereol; 1989; 69(5):395-8. PubMed ID: 2572103
[TBL] [Abstract][Full Text] [Related]
3. [Changes in telogen rate, hair density, hair diameter and rate of growth in androgenetic alopecia of the male. Simultaneously a contribution to the significance of dysplastic hair].
Runne U; Martin H
Hautarzt; 1986 Apr; 37(4):198-204. PubMed ID: 3700106
[TBL] [Abstract][Full Text] [Related]
4. Hair root studies in patients suffering from primary and secondary syphilis.
van der Willigen AH; Peereboom-Wynia JD; van der Hoek JC; Mulder PG; van Joost TH; Stolz E
Acta Derm Venereol; 1987; 67(3):250-4. PubMed ID: 2442940
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
[TBL] [Abstract][Full Text] [Related]
6. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
[TBL] [Abstract][Full Text] [Related]
7. [Local therapy of androgenetic alopecia with 17 alpha-estradiol. A controlled, randomized double-blind study (author's transl)].
Orfanos CE; Vogels L
Dermatologica; 1980; 161(2):124-32. PubMed ID: 7398983
[TBL] [Abstract][Full Text] [Related]
8. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
Koperski JA; Orenberg EK; Wilkinson DI
Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of a novel treatment for androgenetic alopecia using enriched cell culture medium: clinical trials.
Lindenbaum ES; Feitelberg AL; Tendler M; Beach D; Gamliel-Lazarovich A; Har-Shai Y; Hirshowitz B
Dermatol Online J; 2003 Feb; 9(1):4. PubMed ID: 12639462
[TBL] [Abstract][Full Text] [Related]
10. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
Price VH; Menefee E; Sanchez M; Kaufman KD
J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295
[TBL] [Abstract][Full Text] [Related]
11. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
[TBL] [Abstract][Full Text] [Related]
12. Pathobiology of androgenetic alopecia.
Fiurásková M; Kucerová R; Kolár Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):37-41. PubMed ID: 15034603
[TBL] [Abstract][Full Text] [Related]
13. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
[TBL] [Abstract][Full Text] [Related]
14. [Proliferation behavior of the anagen hair bulb in androgenetic alopecia before and after local administration of 17 alpha- propylmesterolone--DNA flow cytophotometry studies].
Kiesewetter F; Schell H; Seidel C; von Hintzenstern J
Z Hautkr; 1990 Dec; 65(12):1115-9. PubMed ID: 2087839
[TBL] [Abstract][Full Text] [Related]
15. Finasteride increases anagen hair in men with androgenetic alopecia.
Van Neste D; Fuh V; Sanchez-Pedreno P; Lopez-Bran E; Wolff H; Whiting D; Roberts J; Kopera D; Stene JJ; Calvieri S; Tosti A; Prens E; Guarrera M; Kanojia P; He W; Kaufman KD
Br J Dermatol; 2000 Oct; 143(4):804-10. PubMed ID: 11069460
[TBL] [Abstract][Full Text] [Related]
16. Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial.
Fischer TW; Burmeister G; Schmidt HW; Elsner P
Br J Dermatol; 2004 Feb; 150(2):341-5. PubMed ID: 14996107
[TBL] [Abstract][Full Text] [Related]
17. Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial.
Oura H; Iino M; Nakazawa Y; Tajima M; Ideta R; Nakaya Y; Arase S; Kishimoto J
J Dermatol; 2008 Dec; 35(12):763-7. PubMed ID: 19239555
[TBL] [Abstract][Full Text] [Related]
18. Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita.
Quercetani R; Rebora AE; Fedi MC; Carelli G; Mei S; Chelli A; Poli E
J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):808-10. PubMed ID: 20946585
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
[TBL] [Abstract][Full Text] [Related]
20. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia.
Maurer M; Handjiski B; Paus R
Am J Pathol; 1997 Apr; 150(4):1433-41. PubMed ID: 9094998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
